WOLVERINE ASSET MANAGEMENT LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$116
-12.8%
3000.0%0.00%
Q2 2023$133
-45.9%
3000.0%0.00%
Q1 2023$246
-99.8%
300
-99.7%
0.00%
-100.0%
Q4 2022$156,468
-9.6%
100,3000.0%0.00%0.0%
Q3 2022$173,0000.0%100,3000.0%0.00%0.0%
Q2 2022$173,000
-51.9%
100,3000.0%0.00%
-50.0%
Q1 2022$360,000
-36.1%
100,300
-11.2%
0.00%
-20.0%
Q4 2021$563,000
-30.4%
113,0000.0%0.01%
-28.6%
Q3 2021$809,000
+373.1%
113,000
+510.8%
0.01%
+600.0%
Q2 2021$171,0000.0%18,5000.0%0.00%0.0%
Q1 2021$171,000
+48.7%
18,500
+42.3%
0.00%0.0%
Q4 2020$115,000
+88.5%
13,000
+141.0%
0.00%
Q3 2020$61,000
-84.5%
5,394
-63.1%
0.00%
-100.0%
Q2 2020$393,000
+222.1%
14,600
-11.0%
0.00%
+100.0%
Q1 2020$122,000
+103.3%
16,400
-10.9%
0.00%
+100.0%
Q4 2019$60,000
+328.6%
18,400
+155.6%
0.00%
Q3 2019$14,000
-85.9%
7,200
-78.8%
0.00%
-100.0%
Q2 2019$99,000
-21.4%
34,0000.0%0.00%
-50.0%
Q1 2019$126,00034,0000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders